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Abstract
Optimal function of immunoisolated islets requires adequate supply of oxygen to met-
abolically active insulin producing beta-cells. Using mathematical modeling, we investi-
gated the influence of the pO2 on islet insulin secretory capacity and evaluated
conditions that could lead to the development of tissue anoxia, modeled for a 300 μm
islet in a 500 μm microcapsule or a 500 μm planar, slab-shaped macrocapsule. The pO2
was used to assess the part of islets that contributed to insulin secretion. Assuming a
500 μm macrocapsule with a 300 μm islet, with oxygen consumption rate (OCR) of
100–300 nmol min−1 mg−1 DNA, islets did not develop any necrotic core. The non-
functional zone (with no insulin secretion if pO2 < 0.1 mmHg) was 0.3% for human
islets (OCR ~100 nmol/min/mg DNA) and 35% for porcine islets (OCR
~300 nmol/min/mg DNA). The OCR of the islet preparation is profoundly affected by
islet size, with optimal size of <250 μm in diameter (human) or <150 μm (porcine). Our
data suggest that microcapsules afford superior oxygen delivery to encapsulated islets
than macrocapsules, and optimal islet function can be achieved by encapsulating multi-
ple, small (<150 μm) islets with OCR of ~100 nmol min−1 mg−1 DNA (human islets) or
~200 nmol min−1 mg−1 DNA (porcine islets).
K E YWORD S
computer modeling, encapsulation, islet, oxygen consumption rate, oxygen diffusion
1 | INTRODUCTION
Immunoisolation of pancreatic islets within bioencapsulation devices has
been proposed to be an effective strategy to circumvent chronic immu-
nosuppression in islet transplantation. Important advances have been
made in the last two decades in the fields of biomaterial device design,
needs for islets in the capsules and the immune responses provoked by
immunoisolated pancreatic islets (Scharp & Marchetti, 2014). Human tri-
als are underway; temporary but reproducible islet function and survival
has been reported with encapsulated pancreatic islet grafts transplanted
into human diabetic patients (Jacobs-Tulleneers-Thevissen et al., 2013).
Also, it has been shown that encapsulation may contribute to solving
shortage of donor tissue as prolonged survival of xenotransplanted islet
grafts has been demonstrated in both chemically induced and autoim-
mune diabetic rodents (Fritschy et al., 1994), dogs (Calafiore et al.,
2004), and nonhuman primates (Dufrane, Goebbels, Saliez, Guiot, &
Gianello, 2006). There is consensus that porcine islets may serve as an
inexhaustible source of islets for human diabetics (Ekser et al., 2012).
Despite these successes and potentials of the approach, a persistent
and fundamental barrier has to be overcome since graft survival variesPaul de Vos and Jonathan R. T. Lakey should be considered co-senior authors
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considerably from several days to months (de Vos, Andersson, Tam,
Faas, & Halle, 2006; de Vos, Faas, Strand, & Calafiore, 2006).
While encapsulation within immunoprotective membranes can be
performed in several ways (macroencapsulation, microencapsulation,
or conformal coating), we will limit further discussion to macro- and
microcapsules, where it has been theorized that graft oxygenation
would be significantly impaired. In macroencapsulation, beta cells
derived from donor islets or stem cells are enveloped in relatively large
diffusion chambers with barriers that selectively exclude immune
responses. In microencapsulation the islets are packaged within micron-
sized capsules ranging around 600um (Riccardo, 2018). In both configu-
rations, islets are unable to connect to host micro-vasculature as the
encapsulation barrier prevents host endothelium from connecting with
the islet. As a result, vital nutrients for cell survival are at a distance and
their continued consumption by islet grafts results in diffusion gradients;
the nutrients will be available in lower concentrations than available in
the ambient interstitium. This phenomenon is more consequential in the
case of oxygen (O2) than other nutrients because (a) the availability of
oxygen to islets depends on O2 partial pressure (pO2) rather than on O2
saturation in the adjacent microvasculature, (b) O2 is poorly soluble in
aqueous media, and (c) islets are metabolically highly active and con-
sume large quantities of O2 relative to their tissue volume. Hypoxia is
therefore considered to be a major contributor to the limitations in
duration of survival of encapsulated islet grafts (Bloch et al., 2006).
Although researchers have long stressed on the indispensability of
adequate tissue oxygenation to ensure favorable transplant outcomes
in encapsulated islet transplantation (Avgoustiniatos & Colton, 2006;
Colton & Avgoustiniatos, 1991; Papas et al., 2007; Souza et al., 2011),
few studies address the severity of this issue and expound on the vari-
ous factors that may influence oxygen bioavailability in encapsulated
islets. To gain more insight into the severity of this problem, we inves-
tigated the influence of a number of critical factors on encapsulated
islet oxygenation by using mathematical modeling algorithms.
1. The partial pressure of oxygen (pO2) at the transplantation site
(peritoneal cavity), which is around 40 mmHg (about 5.5% of satu-
ration pressure) (Nöth et al., 1999).
2. The oxygen consumption rate (OCR) of the islets which is different
in human islets and porcine islets and also dependent on the qual-
ity of the islet preparation (Papas et al., 2007).
3. Device geometry;microcapsules have amore optimal surface to volume
ratiowhich predictably leads to a higher pO2 than inmacrocapsules.
4. The islet load and the spatial distribution of the islets in the device.
5. The influence of islet size.
2 | MATERIALS AND METHODS
The model we have developed predicts the pO2 in the islets of different
sizes and in different capsule geometries. For microcapsules, spherical
geometry can minimize shear stress and friction with surrounding
tissues. Also, the surface area to volume ratio of microcapsules is large
enough for nutrition transportation between surrounding blood vessels
and microcapsules. For macrocapsules, planar structure could provide
large contact area with blood vessels to get enough oxygen supply.
The calculations below were performed for alginate-PLL capsules
(Figures 1 and 2) and alginate-based planarmacrocapsules. Since hypoxic
islets do not secrete insulin in response to stimulation with glucose
(Dionne, Colton, & Yarmush, 1989, 1993), the pO2 will be used to indi-
rectly measure the fraction of islets that contribute to insulin secretion.
2.1 | Modeling assumptions
2.1.1 | Islet size
Simulations were run for uniformly sized and spatially distributed
islets. Two different islet diameters were used: 100 and 300 μm.
2.1.2 | Geometries
For most calculations microcapsule and macrocapsule diameter or
thickness was varied to calculate the effect of the size of the device
on oxygen bioavailability to the islets encapsulated within.
F IGURE 1 Finite-elementmesh and boundary conditions for a single
300 μm islet in a 500 μmalginatemicrocapsule. Oxygen availability at the
surface (Ps) is assumed to be close to the parameter of the equilibrium pO2
F IGURE 2 Finite-element mesh and boundary conditions for four
100 μm islets in a 500 μm alginate microcapsule. Oxygen availability
at the surface (Ps) is assumed to be close to the parameter of the
equilibrium pO2







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4 CAO ET AL.
Other assumptions have to be made regarding geometry of the
encapsulating device, thickness of islet layer, islet viability as mea-
sured by oxygen consumption ratio, concentration of alginate, surface
coating, external pO2, presence of anoxic core, and insulin secretion.
These modeling assumption are provided in Supplement S1.
2.2 | Theoretical mathematical models and equations
The equations used for mathematical modeling is described in Supple-
ment S2. These equations describe zero-order kinetics of the pressure
diffusion and the impact of volume on oxygen partial pressure.
3 | RESULTS
3.1 | Oxygenation in transplanted islets
In addition to the internal ΔpO2, the consumption of O2 inside the
islet causes an external ΔpO2 through the immunoisolation barrier
and presence of any host tissue between the islet and the nearest O2
source (usually blood vessels). The external ΔpO2 can increase by
competition of neighboring transplanted islets for O2.
TotalΔpO2 = InternalΔpO2 +ExternalΔpO2:
Thus, it is evident that the total ΔpO2 can be much greater than
equilibrium tissue pO2 (e.g., 40 mmHg).
When that happens, anoxic cores develop inside the islets.
Oxygenation shows fraction of non-anoxic and non-hypoxic area.
Even if total ΔpO2 less than equilibrium pO2 and so anoxic cores are
absent, the islets can be exposed to low pO2 parameters that can
negatively impact insulin secretion. At such low pO2 parameters, insulin
secretion can be affected even if no anoxic core exists. Depending on
the mode of transplantation, pO2 effects on long-term insulin secretion
have to be taken into consideration.
3.2 | Effect of geometry of the device
The oxygen profiles were modeled for a 300 μm islet in a 500 μm
microcapsule or in a 500 μm planar, slab shaped macrocapsule. This
was done for islets with an OCR of 100 nmol min−1 mg−1 DNA and
an OCR of 300 nmol min−1 mg−1 DNA. The calculations were per-
formed with a pO2 of 40 mmHg. The zone that does not contribute
anymore to insulin secretion, that is, the zone where pO2 drops below
0.1 mmHg, was 3.2% for islets with an OCR of 100 nmol min−1 mg−1
DNA and 50.3% for islets with a pO2 of 300 nmol min
−1 mg−1 DNA.
3.2.1 | Five hundred micrometer diameter
microcapsule
A single 300 μm diameter islet in the center of a 500 μm diameter
alginate capsule has 80% of its volume oxygenated even at the
highest OCR/DNA examined in this study. Insulin secretion varied
between 50 and 97%, depending on the OCR/DNA (Table 1). In
sharp contrast, even 4× (the highest number that allows the use of
axisymmetrical modeling) 100 μm diameter islets in one capsule
exhibit 100% oxygenation and insulin secretory capacity, as shown
in Figure 2.
3.2.2 | Five hundred micrometer thick slab
(macrocapsule)
At 25% vol/vol, 300 μm diameter islets are predicted to be oxygen-
ated for 65–100%, depending on the islet preparation OCR/DNA.
Insulin secretion is predicted to be 25–79%, again depending on the
OCR/DNA (Table 2). Reduction of the alginate concentration from
3 to 1% conveys a small improvement in the order of 1% (of the non-
oxygen limited parameter) in both oxygenation and insulin secretion.
Reduction of the islet content in the composite layer to 20% improves
oxygenation by less than 3% and also improves fractional insulin
secretion, that is, the fraction of islet tissue that is able to release insu-
lin in response to a glucose challenge, by about 5%. Fractional insulin
secretion is a measure of the efficiency at which the transplanted
tissue can be utilized. Bilayers (explained above) of 100 μm diameter
islets perform much better and experience virtually no anoxia and
smaller loss of insulin secretory capacity.
3.2.3 | One thousand, one hundred micrometer thick
slab (macrocapsule)
This design exhibits increased oxygenation by as much as 15% of the
total islet volume and smaller loss of insulin secretory capacity by
about 25%. This result may be counter-intuitive as in this geometry
each islet layer is oxygenated mainly from one side of the slab rather
than both (Figure 3, Table 3). Further analysis is required, but it is
quite possible that the improvement is due to the shorter thickness of
alginate between the islet and the oxygen source in this geometry
(50 μm) relative to the 500 μm thick slab (100 μm).
F IGURE 3 Schematic representation of 1,100 μm slab containing islets in two distinct 300 μm alginate-islet layers. Oxygen availability at the
surface (Ps) is assumed to be close to the parameter of the equilibrium pO2
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The oxygen availability within macrocapsules (Tables 2 and 3)
were different from that of microcapsules (Table 1). For a 500 μm
microcapsule, at an OCR of 100 nmol min−1 mg−1 DNA (human
islet preparations), 0% of the islet was anoxic. At an OCR of
300 nmol min−1 mg−1 DNA (porcine islet preparations) this increased
to 20% of the islet volume. The zone that dropped below pO2
0.1 mmHg, was 3% (OCR of 100 nmol min−1 mg−1 DNA) and 50%
(OCR of 300 nmol min−1 mg−1 DNA) of the islet volume. For a 500 μm
capsules, 0.3% of the islet was anoxic (OCR of 100 nmol/min/mg DNA)
this increased to 35% (OCR of 300 nmol min−1 mg−1 DNA). The
zone that dropped below pO2 0.1 mmHg was 21% (OCR of
100 nmol min−1 mg−1 DNA) and 75% (OCR of 300 nmol min−1 mg−1
DNA) of the islet volume (Figure 4).
3.3 | Effect of islet size, spatial distribution and load
in microcapsules
Next the oxygen profiles were calculated for microencapsulated islets
of 100 μm diameter either as a single islet or as a group of four islets
per capsule, comparing with a microcapsule containing a 300 μm islet.
With four islets of 100 μm, the islet developed no anoxic core
(Figure 5), in comparison to 300 μm islet (Figure 6). The zone that
does not contribute anymore to insulin secretion, was 51.34% for
300 μm islets (Figure 6) while it was 0% for a single 100 μm islets and
for a cluster of four 100 μm islets (Figure 5). Notably, four 100 μm
islets have only 4/27 of the volume of one 300 μm islet.
3.4 | Effect of pO2 at the transplant site
The oxygen tension at the transplant site will drop when encapsulated
islets with a high OCR are implanted (Papas et al., 2005). Therefore,
the effect of lowering pO2 was investigated on microcapsules con-
taining four islets each (Figure 5). Lowering the pO2 to a parameter
to 20 mmHg did not lead to the development of anoxic zone in
microencapsulated islets (Figure 5). The zone that does not contrib-
ute anymore to insulin secretion was 17%.
3.5 | Effect of the oxygen consumption rate of the
islets
As the oxygen consumption rate of islets varies between species and
even between isolations, we calculated the maximum islet-diameter
without anoxic cores for islet preparations with an OCR varying
between 50 and 900 nmol min−1 mg−1 DNA. Note that the higher
parameters are just applied for modeling purposes as the maximum
OCR ever observed was 460 nmol min−1 mg−1 DNA (Personal com-
munication Papas KK). The parameters were calculated for a single-
islet in a 500 μm capsule and for a pO2 parameter of 20, 30, and
40 mmHg. As shown in Figure 7, the OCR of the islet preparation
has the most profound effect on the maximum islet-size that can be
used. Islets larger that 150 μm should be avoided at OCR-parameters
of 200–300 nmol min−1 mg−1 DNA, that is, typical OCR ranges for















































































































































































































































































































































































































































































































































































































































































































































































































































































6 CAO ET AL.
parameter of 100–150 nmol min−1 mg−1 DNA (Papas et al., 2007) diam-
eters up to 250 μm can be applied. The pO2 parameter in the immediate
vicinity of the capsules has a less pronounced effect on the maximum
islet diameter to be applied, but still with every drop of 10 mmHg a
decrease of 50 μm in maximum islet diameter was observed (Figure 7).
4 | DISCUSSION
Sufficient supply of oxygen to islets is not only important for func-
tion and survival of cells in the capsules, but also for host responses.
Hypoxia causes encapsulated islets to become necrotic and to produce
danger-associated molecular patterns (DAMPS) (Paredes-Juárez,
Spasojevic, Faas, & de Vos, 2014). DAMPS are highly immunogenic
and can provoke severe host responses. Also, islets under hypoxic
conditions produce nitric oxide (NO) that can induce cell-death in the
islets (Paredes-Juarez et al., 2015). Hypoxia also induces upregulation
of chemotactic cytokines such as monocyte chemoattractant protein
1 (MCP-1), which attract proinflammatory cells such as macrophages
and neutrophils. These cells will induce profound damage to the graft in
the immediate period after transplantation (Fraker, Alejandro, & Ricordi,
2002). Thus, hypoxia not only induces direct deleterious effects on the
islets in the capsules, but it will also result in a brisk immune response
against the encapsulated grafts.
An improved understanding of the interplay of oxygen diffusion
and consumption rate in devices is critical to improve oxygen supply
to islets. Current efforts to solve the oxygen supply hurdle include
engineering of islets to render them more resistant to hypoxic condi-
tions and supply of components to enhance oxygen tensions in cap-
sules. These include administration of organic molecules with high
oxygen retention capabilities such as perfluorocarbons, silicone oils,
or soybean oils (Cowley et al., 2012; Fraker et al., 2002; Papas et al.,
2005). Another approach is the supply of oxygen by an external oxy-
gen tank (Barkai et al., 2013).
The results of this study highlight the multitude of device and tis-
sue parameters that influence oxygen bioavailability within islet
encapsulation devices. Several published studies have demonstrated
that smaller islets are more likely to have a favorable outcome after
intraportal or renal subcapsular transplantation (Lehmann et al., 2007;
Macgregor et al., 2006). Two-dimensional axi-symmetric modeling
predicts that encapsulated islet preparations that contain smaller islets
(~100 μm) are less likely to demonstrate anoxia or suffer a reduction
in insulin release when compared with large islets (~300 μm) after
F IGURE 4 pO2 surface plot for
300 μm diameter islets encapsulated
within a 500 μm-thick alginate capsule,
comparing islet with OCR of
100 nmol/min/mg DNA versus 300 nmol
min−1 mg−1 DNA. pO2 varies from
40 mmHg (red) to 0.1 mmHg (white).
Oxygen availability at the surface (Ps) is
assumed to be close to the parameter of
the equilibrium pO2 (40 mmHg
intraperitoneally)
F IGURE 5 pO2 surface plot for 4 × 100 μm diameter islets in a
single 500 μm diameter alginate capsule. pO2 varies from 40 mmHg
(red) to 0.1 mmHg (white). Oxygen availability at the surface (Ps) is
assumed to be close to the parameter of the equilibrium pO2
(40 mmHg intraperitoneally)
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intraperitoneal transplantation, suggesting favorable outcomes with
smaller islets.
The results of this study also suggest that islet with lower OCRs
are comparatively less likely to experience anoxia and a decline in
insulin release after encapsulation and intraperitoneal transplantation.
While no studies have evaluated islet OCR in encapsulated islets
post-transplantation, with unencapsulated islets transplanted into por-
tal veins or renal subscapular spaces, islet OCR has been demon-
strated to be a reliable predictor of a successful outcome; the higher
the OCR, the greater the chances of hyperglycemia reversal in dia-
betic recipients (Papas et al., 2015; Pepper et al., 2012).
Our model also predicts that human islet preparations (OCR
~100 nmol/min/mg DNA) should theoretically fare better than por-
cine islet preparations (OCR 200-300 nmol/min/mg DNA). While no
comparative studies have been performed to specifically evaluate this
hypothesis in vivo, Hals IK et al., noted that encapsulated human islets
did not demonstrate evidence of hypoxia-induced graft injury post
transplantation (Hals, Rokstad, Strand, Oberholzer, & Grill, 2013);
unfortunately, no similar studies have been performed with encapsu-
lated porcine islets to date.
Modeling results also predict that oxygen bioavailability is greater
within microcapsules than macrocapsules, albeit there are limitations
to the scope of this conclusion as only two symmetric alginate-based pla-
nar macrocapsule constructs were evaluated. Cornolti R et al., reported
that after 48 hours of in vitro culture, both micro and macroencapsulated
bovine islets demonstrated no significant changes in OCR; however, only
one hollow-fiber macrocapsule construct was evaluated in this study and
no in vivo experiments were performed which makes it difficult to inter-
pret the results reported (Cornolti et al., 2009). Our results might also
explain why researchers have reported successful return to euglycemia
only when either oxygen supplementation (Ludwig et al., 2012; Pedraza,
Coronel, Fraker, Ricordi, & Stabler, 2012) or prevascularization (Kriz
et al., 2012; Pepper et al., 2015) was employed with macrocapsule
devices transplanted into diabetic recipients. However, results obtained
with microcapsules have been far more encouraging (Hals et al., 2013;
Pareta et al., 2014; Yang et al., 2016).
4.1 | Model validation
In vivo study has shown presence of oxygen gradient in the capsule.
However, in vitro validation would be necessary to measure oxygen
gradient within islets. Also, since an oxygen sink can significantly
change pO2 at the surface of each device, pO2 need to be tracked for
device with oxygen sink. The development of implantable oxygen sen-
sors would enable determination of tissue pO2 at various implant
sites, thus greatly increasing the predictive accuracy of our model
(Weidling, Sameni, Lakey, & Botvinick, 2014).
5 | CONCLUSIONS
Encapsulated islet oxygenation is a serious issue. Modeling is a powerful
tool to evaluate designs before experiments are carried out. Modeling is
F IGURE 6 pO2 surface plot for 300 μm diameter islets
encapsulated within a 500 μm-thick alginate capsule. pO2 varies from
40 mmHg (red) to 0.1 mmHg (white). Oxygen availability at the
surface (Ps) is assumed to be close to the parameter of the equilibrium
pO2 (40 mmHg intraperitoneally)
F IGURE 7 Effect of islet preparation OCR on encapsulated islet
oxygenation. The graph predicts the “maximum allowable islet
diameter without an anoxic core” for human and porcine islet
preparations encapsulated within a 500 μm diameter capsule
assuming a ratio of one 300 μm diameter islet per capsule. If the pO2
at the capsule surface is lowered, the “maximum allowable islet
diameter without an anoxic core” reduces correspondingly. OCR,
oxygen consumption rate
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limited by the accuracy of the assumptions and parameters used, but it is
reliable as long as measurements for parameters that are preparation-
specific (e.g., OCR) or are not well characterized (e.g., equilibrium pO2 at
transplantation site before and after transplantation) taken into account
to make specific predictions and accurately evaluate biomaterial device
design to improve transplantation outcomes.
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